Back to today’s briefing

Story perspectives

Wegovy Launches in India: A Game-Changer for Obesity

7/9/2025

39 5

Summary

Story summary

Novo Nordisk has introduced Wegovy, a groundbreaking weight-loss drug, in India after receiving regulatory approval. This once-weekly injection, infused with semaglutide, aims to curb appetite and tackle obesity-related health challenges. With obesity rates soaring in India, Wegovy's arrival marks a pivotal step in the global fight against obesity and heart disease, promising a healthier future for many.

1 of 1

Story summary

Novo Nordisk has introduced Wegovy, a groundbreaking weight-loss drug, in India after receiving regulatory approval. This once-weekly injection, infused with semaglutide, aims to curb appetite and tackle obesity-related health challenges. With obesity rates soaring in India, Wegovy's arrival marks a pivotal step in the global fight against obesity and heart disease, promising a healthier future for many.